Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: Relationship to multiple lipoprotein phenotype

被引:31
|
作者
Georgieva, AM
van Greevenbroek, MMJ
Krauss, RM
Brouwers, MCGJ
Vermeulen, VMMJ
Robertus-Teunissen, MG
van der Kallen, CJH
de Bruin, TWA
机构
[1] Univ Maastricht, Dept Med, Lab Mol Metab & Endocrinol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[2] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA
关键词
sd LDL; apolipoprotein B; triglycerides; insulin resistance; VLDL;
D O I
10.1161/01.ATV.0000119681.47218.a4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-The present study addresses the presence of distinct metabolic phenotypes in familial combined hyperlipidemia (FCHL) in relation to small dense low-density lipoprotein (sd LDL) and very low-density lipoprotein (VLDL) subclasses. Methods and Results-Hyperlipidemic FCHL relatives (n=72) were analyzed for LDL size by gradient gel electrophoresis. Pattern B LDL (sd LDL, particle size <258 angstrom) and pattern A LDL (buoyant LDL, particle size >= 258 angstrom) were defined. Analyses showed bimodal distribution of LDL size associated with distinct phenotypes. Subjects with predominantly large, buoyant LDL showed a hypercholesterolemic phenotype and the highest apo B levels. Subjects with predominantly sd LDL showed a hypertriglyceridemic, low high-density lipoprotein (HDL) cholesterol phenotype, with moderately elevated apoB, total cholesterol level, and LDL cholesterol level. Subjects with both buoyant LDL and sd LDL (pattern AB, n=7) showed an intermediate phenotype, with high normal plasma triglycerides. VLDL subfraction analysis showed that the sd LDL phenotype was associated with a 10-times higher number of VLDL1 particles of relatively lower apo AI and apo E content, as well as smaller VLDL2 particles, in combination with increased plasma insulin concentration in comparison to pattern A. Conclusions-The present observations underscore the importance of the VLDL triglyceride metabolic pathway in FCHL as an important determinant of the phenotypic heterogeneity of the disorder.
引用
收藏
页码:744 / 749
页数:6
相关论文
共 50 条
  • [31] INTESTINAL VERY LOW-DENSITY LIPOPROTEIN PRODUCTION
    JONES, AL
    OCKNER, RK
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1972, 8 (06): : 836 - &
  • [32] VERY LOW-DENSITY LIPOPROTEIN METABOLISM IN ABETALIPOPROTEINEMIA
    GULBRANDSEN, C
    EVANS, V
    LEES, RS
    NICHOLS, A
    JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (06): : A40 - +
  • [33] VERY LOW-DENSITY LIPOPROTEIN BINDING TO ADIPOCYTES
    DESAI, KS
    STEINER, G
    TAKEUCHI, I
    HOLLENBERG, CH
    BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 620 (03) : 341 - 351
  • [34] DIFFERENCES IN CARBOHYDRATE CONTENT OF LOW-DENSITY LIPOPROTEIN SUBCLASSES
    KRAUSS, RM
    LABELLE, M
    ARTERIOSCLEROSIS, 1988, 8 (05): : A596 - A596
  • [35] METABOLIC PROPERTIES OF HUMAN LOW-DENSITY LIPOPROTEIN SUBCLASSES
    BURKE, DJ
    KESANIEMI, A
    BELTZ, W
    GRUNDY, S
    KRAUSS, RM
    ARTERIOSCLEROSIS, 1982, 2 (05): : A417 - A417
  • [36] A MACROPHAGE RECEPTOR THAT RECOGNIZES OXIDIZED LOW-DENSITY LIPOPROTEIN BUT NOT ACETYLATED LOW-DENSITY LIPOPROTEIN
    SPARROW, CP
    PARTHASARATHY, S
    STEINBERG, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (05) : 2599 - 2604
  • [37] Biosensors to detect low-density lipoprotein and oxidized low-density lipoprotein in cardiovascular disease
    Ranjbari, Sara
    Ritchie, Leona A.
    Arefinia, Reza
    Kesharwani, Prashant
    Sahebkar, Amirhossein
    SENSORS AND ACTUATORS A-PHYSICAL, 2024, 365
  • [38] Low-density lipoprotein subclasses: mechanisms of formation and modulation
    Griffin, BA
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1997, 56 (02) : 693 - 702
  • [39] Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
    Katsiki, Niki
    Vrablik, Michal
    Banach, Maciej
    Gouni-Berthold, Ioanna
    PHARMACEUTICALS, 2023, 16 (04)
  • [40] Is directly measured low-density lipoprotein clinically equivalent to calculated low-density lipoprotein?
    Baruch, Lawrence
    Agarwal, Sanjay
    Gupta, Bhanu
    Haynos, Ann
    Johnson, Swapna
    Kelly-Johnson, Katelyn
    Eng, Calvin
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (04) : 259 - 264